Lavipharm S.A (LAVI.AT)
Lavipharm S.A reported revenue of 62.6M EUR for the year ending 31 December 2025, up 18.2% from 52.9M a year earlier.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in EUR.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in EUR.
| Figure | Period | Amount | Year on year |
|---|
| Revenue |
2025 · ending 31 December 2025 |
62.6M |
+18.2% |
| Gross Profit |
2025 · ending 31 December 2025 |
30.3M |
+20.8% |
| Operating Income |
2025 · ending 31 December 2025 |
9.3M |
+68.8% |
| Net Income |
2025 · ending 31 December 2025 |
6M |
-33.3% |
| Cost of Revenue |
2025 · ending 31 December 2025 |
32.3M |
+15.8% |
| Operating Cash Flow |
2025 · ending 31 December 2025 |
6.7M |
+43.7% |
| Free Cash Flow |
2025 · ending 31 December 2025 |
2M |
— |
Revenue and profit by financial year
As filed, in EUR. A year the filing does not support is not listed.
| Year | Ending |
Revenue | Operating Income | Net Income | Free Cash Flow |
|---|
| 2025 | 2025-12-31 |
62.6M | 9.3M | 6M | 2M |
|---|
| 2024 | 2024-12-31 |
52.9M | 5.5M | 9M | -5M |
|---|
| 2023 | 2023-12-31 |
47.8M | 5.2M | 1.9M | -3.8M |
|---|
| 2022 | 2022-12-31 |
39.1M | 3.9M | 830K | -32.3M |
|---|
| 2021 | 2021-12-31 |
39.7M | 4.6M | 1.7M | 2.2M |
|---|
| 2020 | 2020-12-31 |
37.6M | 5.2M | 2.1M | 1.4M |
|---|
Every period
Revenue Annual
| Period | Ending | Revenue |
|---|
| FY25 | 2025-12-31 | 62.6M |
|---|
| FY24 | 2024-12-31 | 52.9M |
|---|
| FY23 | 2023-12-31 | 47.8M |
|---|
| FY22 | 2022-12-31 | 39.1M |
|---|
| FY21 | 2021-12-31 | 39.7M |
|---|
Gross Profit Annual
| Period | Ending | Gross Profit |
|---|
| FY25 | 2025-12-31 | 30.3M |
|---|
| FY24 | 2024-12-31 | 25.1M |
|---|
| FY23 | 2023-12-31 | 22.1M |
|---|
| FY22 | 2022-12-31 | 17.6M |
|---|
| FY21 | 2021-12-31 | 15.9M |
|---|
Operating Income Annual
| Period | Ending | Operating Income |
|---|
| FY25 | 2025-12-31 | 9.3M |
|---|
| FY24 | 2024-12-31 | 5.5M |
|---|
| FY23 | 2023-12-31 | 5.2M |
|---|
| FY22 | 2022-12-31 | 3.9M |
|---|
| FY21 | 2021-12-31 | 4.6M |
|---|
Net Income Annual
| Period | Ending | Net Income |
|---|
| FY25 | 2025-12-31 | 6M |
|---|
| FY24 | 2024-12-31 | 9M |
|---|
| FY23 | 2023-12-31 | 1.9M |
|---|
| FY22 | 2022-12-31 | 830K |
|---|
| FY21 | 2021-12-31 | 1.7M |
|---|
Cost of Revenue Annual
| Period | Ending | Cost of Revenue |
|---|
| FY25 | 2025-12-31 | 32.3M |
|---|
| FY24 | 2024-12-31 | 27.9M |
|---|
| FY23 | 2023-12-31 | 25.7M |
|---|
| FY22 | 2022-12-31 | 21.4M |
|---|
| FY21 | 2021-12-31 | 23.8M |
|---|
Operating Cash Flow Annual
| Period | Ending | Operating Cash Flow |
|---|
| FY25 | 2025-12-31 | 6.7M |
|---|
| FY24 | 2024-12-31 | 4.6M |
|---|
| FY23 | 2023-12-31 | 284K |
|---|
| FY22 | 2022-12-31 | 3.3M |
|---|
| FY21 | 2021-12-31 | 4.1M |
|---|
Free Cash Flow Annual
Operating cash flow minus capital expenditure.
| Period | Ending | Free Cash Flow |
|---|
| FY25 | 2025-12-31 | 2M |
|---|
| FY24 | 2024-12-31 | -5M |
|---|
| FY23 | 2023-12-31 | -3.8M |
|---|
| FY22 | 2022-12-31 | -32.3M |
|---|
| FY21 | 2021-12-31 | 2.2M |
|---|